Israel Active

UK’s University Hospital Birmingham has reduced the time taken to remove tumors by up to three hours thanks to 3D-printed cutting guides produced on a J5 MedJet printer from Israel’s Stratasys. It is transforming the way tumors are removed from head and neck cancer patients.

Treatment for asthma. (TY ) Israel’s Teva has bought the rights to complete the development of BD9 - an antibody-based therapy for the treatment of asthma and atopic dermatitis from Israel’s Biolojic Design (see previously). Biolojic's AI platform generates antibodies that have predictable functions.

Israel’s Scinai Immunotherapeutics has announced successful preclinical trial results of its innovative anti‑IL‑17 VHH antibody (‘NanoAb’) as a local treatment for the large and underserved population of patients with mild to moderate plaque psoriasis.

The US FDA has cleared the bio-integrative technology from Israel’s Ossio (see previously) to be used in orthopedic surgery for children and adolescents needing bone realignments, fusions or fracture fixation.

Israel’s Compugen (see previously) only had six months’ cash left when it was rescued by Gilead Sciences in a deal worth up to $848 million. Gilead will license Compugen’s pre-clinical cancer antibody COM503 that frees up the peptide InterLeukin 18 (IL-18) to destroy tumors.

Israel’s Belkin Vision (previously Belkin Laser – see ) has received US FDA clearance for the use of its automatic and noninvasive glaucoma laser surgery device. The Eagle is the first and only contactless laser surgery for glaucoma patients.

Researchers at Israel’s Weizmann Institute have also been studying the brain. In lab tests they found that trauma in early life caused problems in adults that showed up on brain scans. But a short treatment of diazepam soon after trauma erased those signs on adult brain scans.

Israel’s Tech4animals lab (see previously) has developed an algorithm that detects the canine breathing condition known as Brachycephalic Obstructive Airway Syndrome (BOAS). It is common in dogs such as boxers, pugs and French bulldogs that have been bred with short snouts.

Israel’s FIZE Medical has developed a new AI device that measures production of urine by the kidneys via a patient catheter. It identifies problems with kidneys, heart, medication, etc. Fize has FDA approval and has completed a pilot at Nationwide Children’s Hospital in Columbus, Ohio.

Israel’s Curalife manufactures Curalin – a herbal supplement formulated to treat diabetes but with anecdotal indications for stress reduction, improved metabolism and even insomnia. It contains nine herbs based on Ayurvedic medicine - an ancient Indian practice.